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ISSN 1550-8307/$36.00CASE REPORTS OF IDIOPATHIC THROMBOCYTOPENIA
UNRESPONSIVE TO FIRST-LINE THERAPIES TREATED
WITH TRADITIONAL HERBAL MEDICINES BASED ON
SYNDROME DIFFERENTIATION
Juno Yang, KMD, PhD1,a Beom-Joon Lee, KMD, PhD2,a and
Jun-Hwan Lee, KMD, PhD3,4#The objective of our study is to present two cases showing the
effects of traditional Korean herbal medicines based on tradi-
tional Korean medicine (TKM) for the treatment of immune
thrombocytopenic purpura (ITP). One patient showed no
response to treatment with steroids and an immunosuppres-
sive agent. Moreover, liver toxicity and side effects of steroids
were evident. However, after he ceased conventional treatment
and started to take an herbal medicine, his liver function
normalized and the steroid side effects resolved. Ultimately, he
achieved complete remission. Another patient with ITP had
sustained remission after steroid therapy in childhood, but
extensive uterine bleeding and thrombocytopenia recurred
when she was 16 years old. She was managed with steroids
again for 2 years, but severe side effects occurred, and
eventually she ceased taking steroids. She refused ae.kr
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s.org/licenses/by-nc-nd/4.0/).splenectomy, and was then treated with a herbal medicine
for 7 months, ultimately leading to sustained remission
again. Many patients with resistance to ﬁrst-line treatments
tend to be reluctant to undergo a splenectomy, considered a
standard second-line treatment. In conclusion, herbal med-
icines, based on TKM, may offer alternative treatments for
persistent or chronic ITP that is resistant to existing ﬁrst-line
treatments.
Keywords: idiopathic thrombocytopenic purpura, traditional
Korean medicine, syndrome differentiation, herbal medicine
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Primary idiopathic thrombocytopenic purpura (ITP) or pri-
mary immune thrombocytopenia, is characterized by platelet
destruction (to o100  109/L) in the absence of other causes
or disorders that may be associated with thrombocytopenia.
The main clinical challenge of primary ITP lies in the
increased risk of bleeding, although bleeding symptoms,
including epistaxis, petechiae, bruising, and purpura, are not
always present.1The primary ﬁrst-line treatment of ITP is corticosteroids and
intravenous immunoglobulin (IVIG) or anti-D globulin (anti-
D). Corticosteroids are usually the ﬁrst choice, and IVIG or
anti-D is used as ﬁrst-line treatment for patients for whom
steroids are contraindicated. If ﬁrst-line therapies fail, splenec-
tomy, rituximab, immunosuppressive agents (e.g., cyclophos-
phamide and azathioprine), and thrombopoietin-receptor
agonists (e.g., romiplostim and eltrombopag) may be consid-
ered as second-line treatments.2,3
Splenectomy has also been regarded as a standard second-
line treatment in the management of patients who are
refractory to ﬁrst-line treatments. Other second-line therapies
are considered after the failure of splenectomy, but they are
expensive and have various side effects.3 However, many
patients are reluctant to undergo a splenectomy because of
the unpredictability of the response,4 its invasiveness,5 and
possible complications.6,7 Thus, many patients tend to post-
pone or avoid a splenectomy when possible.8
Between adults and children with ITP, there are several
clinical differences. In the case of adult ITP treatment, the
spontaneous remission rate is lower, corticosteroids are used
more frequently, and splenectomy is more often considered.9
Syndrome differentiation is not only a typical traditional
Korean medical diagnostic system but also a key concept in
the practice of traditional Korean medicine (TKM). According1EXPLORE ] 2016, Vol. ], No. ]
http://dx.doi.org/10.1016/j.explore.2016.10.007
Fig. 1. Timeline of interventions and outcomes in case 1. PDN,to the syndrome differentiation diagnostic system, a disease
can be categorized into any of several different patterns based
on the analysis of clinical information obtained from the
following four major traditional diagnostic procedures: obser-
vation, listening, questioning, and pulse analyses. These
patterns are also used in traditional medical treatments,
including the prescription of herbal medicine and acupunc-
ture.10–12
There have been some reports demonstrating the efﬁcacy of
herbal medicine instead of ﬁrst-line treatments for ITP,13,14
and there was one report of treatment of childhood persistent
ITP with herbal medicine.15 However, there has been no
report demonstrating the effectiveness of herbal medicine in
treating adult persistent or chronic ITP patients who were
unresponsive to standard ﬁrst-line therapies, based on the
syndrome differentiation diagnostic system.
Thus, in this article, we present two ITP patients, both of
whom were unresponsive to the ﬁrst-line treatment or discon-
tinued conventional treatment due to the side effects of
steroids. Nonetheless, they achieved complete or partial
remission by taking herbal medicines based on syndrome
differentiation without requiring a splenectomy.prednisone; AZ, azathioprine; CS, cyclosporine; TKM, traditional
Korean medicine, red arrow: TKM clinic visit day.CASE 1
A 25-year-old male patient, a Korean student who resided in
the Philippines, visited a local hospital with high fever
(4401C) and a decreased platelet count (o100  109/L) in
January 2011, and was treated for dengue fever. The fever
became stable after 1 week, but the thrombocytopenia per-
sisted. A bone marrow biopsy showed moderate megakaryo-
cytic hyperplasia, and treatment with oral prednisone 60 mg/d
was started for newly diagnosed ITP on February 4. However,
the patient was unresponsive to the treatment, and azathio-
prine 100 mg/d and prednisone 180 mg/d were administered
orally on February 18. Subsequently, the patient started to
suffer from side effects of the steroid, including weight gain
and swelling, and liver toxicity was detected in a biochemical
analysis on March 22. The azathioprine was replaced by
cyclosporine 200 mg/d due to the liver toxicity. On April
26, because of persistent liver toxicity, the immunosuppressive
drug—cyclosporine was stopped, and prednisone was reduced
to 60 mg/d. However, the platelet count still did not increase.
Moreover, the patient could not walk properly due to vertebral
pain, weight gain, and peripheral edema in both legs. The
patient eventually came to Korea and visited our clinic in a
wheelchair on August 5 (Fig. 1).
On physical examination, the patient was unable to walk
due to severe back pain and peripheral edema and had a
cutaneous wound on his ankle that was not healing well. He
was suffering from side effects of the steroid: moon face,
edema, weight gain, muscle weakness, and pain in the back
and knees. An erythematous facial complexion and dark red-
colored tiny petechiae were observed around his trunk and
neck. The patient also reported fatigue, mild irritability,
insomnia, thirst, and yellow urine. A taut, rapid, and weak
pulse was found on pulse examination. A dark red and dry
tongue was observed. However, he had no bleeding symp-
toms, and no splenomegaly. Laboratory analyses showed a2 EXPLORE ] 2016, Vol. ], No. ]platelet count of 49  109/L and aspartate aminotransferase
(AST)/alanine transaminase (ALT) of 211/230 UI/L. The
patient was taking oral prednisone 60 mg/d, calcium carbonate
40 mg/d, furocemide 40 mg/d, and celecoxib 400 mg/d.
The patient was administered modiﬁed jigolpieum water
extract orally (Table 1) three times per day under a diagnosis
of persistent ITP, and furocemide was stopped. After three
weeks, his platelet count increased to 126  109/L, and the
AST/ALT ratio decreased to 130/150 UI/L. The prednisone
was tapered down to 30 mg/d. However, the platelet count
then fell to 49  109/L because of the reduced steroid dose.
Thus, the herbal medicine was changed to a modiﬁed
seongyutang with Salviae miltiorrhizae radix and Scutellariae
radix water extract (Table 2). Subsequently, the platelet
count increased again, and the AST/ALT ratio decreased
gradually. After three months, the steroid was discontinued.
After four months, the platelet counts and AST/ALT ratio
were 232  109/L and 54/62 IU/L, respectively, the cutaneous
wound had healed, and the general condition of the patient
had improved. Thus, the dose of the herbal medicine was
tapered to two-thirds the previous dose. After ﬁve months, the
platelet counts and AST/ALT ratio were 184  109/L and 41/
47 IU/L, respectively, indicating a complete response; how-
ever, the platelet count was maintained at 4100  109/L3.
Given the patient's recovery, the herbal medicine was discon-
tinued on January 7, 2012. Even with no medication, there
was no bleeding sign, and the platelet count was still4150 
109/L on May 15, 2014 (Fig. 2).CASE 2
This 20-year-old female patient suffered from a common cold
when she was eight years old. A local pediatric doctor
administered a cutaneous intermuscular injection ofITP treated with traditional herbal medicines
Table 1. Ingredients and Doses of the Modiﬁed jigolpieum Water Extract Used in Case 1 and Activities of the Herbs
Pharmaceutical Name Total Daily Dose (g/d) Main Activity of Herbal Drug in This Case
Lycii radicis cortex 15 Clear deﬁciency in heat
Moutan cortex 15 Activate blood and resolve stasis
Ginseng radix 12 Tonify Qi and engender ﬂuid
Zingiberis rhizoma siccus 12 Tonify Qi and warm the interior
Cinnamomi cortex spissus 12 Tonify Qi and tonify Yang
Glycyrrhizae radix 6 Tonify Qi and harmonize Qi and blood
Angelicae gigantis radix 6 Nourish Yin and harmonize the blood
Cnidii rhizoma 6 Nourish Yin and activate blood; move Qi
Paeoniae radix rubra 6 Nourish Yin and activated blood; resolve stasis
Rehmanniae radix 6 Nourish Yin; enrich Yin; and subdue Yang
Poria (Hoelen) 12 Drain dampness and invigorate spleen and stomach
Alismatis rhizoma 12 Induce diuresis to alleviate edemaantibiotics in her hip, which produced an extensive hematoma
in the injected area. The patient was transferred to the
emergency room and treated with IVIG; however, treatment
with steroids was maintained under a diagnosis of ITP. A bone
marrow biopsy revealed erythroid hyperplasia and increased
megakaryocytes. Despite the severe side effects of the steroids
(stomach irritation, swelling, weight gain, and moon face), the
patient achieved a sustained remission approximately after six
months. When the patient was 16 years old, she experienced
extensive uterine bleeding, and her platelet count decreased to
8  109/L on January 10, 2010. She was treated with two
cycles of IVIG, 1.0 g/kg/d intravenously for two days, and with
oral steroids 60 mg/d based on a diagnosis of relapsed severe
chronic ITP. She continued the oral steroid treatment for
approximately two years, and she showed a partial response
and sustained remission. However, the platelet count decreased
to 37  109/L on February 2, 2011. Furthermore, steroids side
effects such as bone pain, alopecia, weight gain, swelling, and
ﬁbromyalgia made the patient's symptoms much more serious.
She ﬁnally stopped taking the steroids and visited our clinic
seeking an alternative treatment on April 4, 2011 (Fig. 3).Table 2. Ingredients and Doses of the Modiﬁed seongyutang Water E
Pharmaceutical Name Total Daily Dose (g/d)
Astragali radix 30
Ginseng radix 12
Zingiberis rhizoma siccus 12
Cinnamomi cortex spissus 12
Glycyrrhizae radix 6
Angelicae gigantis radix 6
Cnidii rhizoma 6
Paeoniae radix rubra 6
Rehmanniae radix 6
Atractylodis rhizoma 6
Salviae miltiorrhizae radix 15
Scutellariae radix 15
ITP treated with traditional herbal medicinesOn physical examination, the patient had no bleeding or
petechiae. Her general condition was poor, and she felt
tired all the time. She was reported to have experienced
lassitude, emaciation, low voice, dry mouth and throat,
dizziness, mild insomnia, spontaneous sweating, intermit-
tent palpitations, and delayed menstruation cycles. A thin,
weak, and rapid pulse was noted on pulse examination.
A pale tongue proper without coating was observed on
tongue examination.
She was treated with oral modiﬁed seongyutang with
Salviae miltiorrhizae radix, Artemisiae apiaceae herba, Lycii
radicis cortex, Biotae cacumen, and Lonicerae ﬂos water extract
(Table 3) three times per day. Although her platelet count
temporarily fell to 44  109/L due to hives, supposedly
caused by the summer heat, her platelet count increased
gradually for seven months. On November 11, 2011, her
platelet count was maintained at 61  109/L and we stopped
the herbal medicine and continued to observe the patient.
Since then, there has been no bleeding sign; her platelet
count was 90  109/L on July 6, 2012, and 93  109/L on
June 5, 2014 (Fig. 4).xtract Used in Case 1 and Activities of the Herbs
Main Activity of Herbal Drug in this Case
Tonify Qi and secure the exterior
Tonify Qi and engender ﬂuid
Tonify Qi and warm the interior
Tonify Qi and tonify Yang
Tonify Qi; harmonize Qi and blood
Nourish Yin and harmonize the blood
Nourish Yin, activate blood, and move Qi
Nourish Yin and activated blood; resolve stasis
Nourish Yin; enrich Yin; and subdue Yang
Resolve dampness to move Qi and fortify the spleen
Tonify blood and activated blood to resolve stasis
Purge ﬁre, clear heat, and detoxify
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Fig. 2. Changes in platelet counts and AST/ALT ratio during the course of treatment in case 1. Plt, platelets; AST, aspartate aminotransferase;
ALT, alanine transaminase.DISCUSSION
Primary ITP is an acquired autoimmune disorder characterized
by a low platelet count in the peripheral blood without any
recognized cause, mediated by platelet antibodies that accel-
erate platelet destruction, and inhibit their production.2,16
Population-based studies have estimated the incidence of ITP
to be 1.9–6.4 per 100,000 children and 3.3 per 100,000 adults
per year.17 However, although two-thirds of newly diagnosedFig. 3. Timeline of interventions and outcomes in case 2. PDN,
prednisone; IVIG, intravenous immunoglobulin, red arrow: TKM clinic
visit day.
4 EXPLORE ] 2016, Vol. ], No. ]children obtain complete responses with the ﬁrst-line treat-
ment, 30% of children with newly diagnosed ITP progress
to persistent or chronic ITP.18 In Korea, 22.5–37% of children
with ITP develop persistent or chronic ITP,19 whereas 60%
of adults with newly diagnosed ITP maintain a response after
initial treatment with standard ﬁrst-line therapies, although
most adult patients exhibit chronic relapse after one year.20,21
Second-line therapies, including splenectomy, rituximab,
immunosuppressive agents (e.g., cyclophosphamide and aza-
thioprine), and thrombopoietic-receptor agonists (e.g., romi-
plostim and eltrombopagand), are indicated for those patients
who are unresponsive to or relapse after initial ﬁrst-line
therapies.3 For decades, splenectomy has been considered a
standard second-line therapy because it is highly effective and
inexpensive compared with other second-line therapies.2,22
Additionally, each of the other second-line therapies has
unique potential toxicities, such as immune suppression,
secondary malignancies, hypertension, and hepatic toxicity.
Thus, splenectomy has been recommended for patients who
fail corticosteroid therapy.3 Nevertheless, the number of
patients who opt to avoid a splenectomy has increased.5,23
Many patients are simply reluctant to remove a healthy organ
that has multiple hematological and immunological functions,
and to undergo an invasive and irreversible procedure. More-
over, the procedure itself can cause mortality and increases the
morbidity of various complications, including bacterial sep-
sis,7 vascular disease such as venous thromboembolism or
atherosclerosis,24 thrombosis,25 prolonged hospitalization,
readmission to the hospital, and the requirement of
additional interventions.6,8 In children, in particular, post-
splenectomy sepsis has risen to 3%, and an increased risk of
sepsis probably persists for life.2
In Korea, there are various norms for ITP treatment. Most
patients receive their initial diagnosis and management from aITP treated with traditional herbal medicines
Table 3. Ingredients and Doses in the Modiﬁed seongyutang Water Extract Used in Case 2 and Activities of the Herbs
Pharmaceutical Name Total Daily Dose (g/d) Main Activity of Herbal Drug in this Case
Astragali radix 30 Tonify Qi and secure the exterior
Ginseng radix 12 Tonify Qi and engender ﬂuid
Zingiberis rhizoma siccus 12 Tonify Qi and warm the interior
Cinnamomi cortex spissus 12 Tonify Qi and tonify Yang
Glycyrrhizae radix 6 Tonify Qi; harmonize Qi and blood
Angelicae gigantis radix 6 Nourish Yin and harmonize the blood
Cnidii rhizoma 6 Nourish Yin, activate blood, and move Qi
Paeoniae radix rubra 6 Nourish Yin and activated blood; resolve stasis
Rehmanniae radix 6 Nourish Yin; enrich Yin; and subdue Yang
Salviae miltiorrhizae radix 15 Tonify blood and activated blood; resolve stasis
Artemisiae apiaceae herba 6 Clear heat to cool the blood
Lycii radicis cortex 15 Clear deﬁciency heat
Biotae cacumen 30 Dissipate blood stasis and resolve phlegm
Lonicerae ﬂos 6 Clear heat to cool the blood and detoxifyhematologist and routinely undergo a bone marrow examina-
tion. Regarding treatment, corticosteroids and anti-D are used
commonly as ﬁrst-line pharmacological treatments over IVIG,
and splenectomy is generally considered for ITP patients who
show ﬁrst-line treatment resistance.26,27 Nonetheless, because
of complications, many patients in Korea have also been
opting to defer a splenectomy as long as possible, and the need
for alternative therapies before splenectomy to manage ITP
unresponsive to ﬁrst-line therapy has, therefore, increased.
The main treatment goal in all ITP patients must be to
maintain a safe platelet count, that is, not to normalize the
platelet count, but keep it at a level that will prevent or stop
major bleeding. However, no treatment objective in persistent
or chronic ITP has been ﬁrmly deﬁned as yet, and it is often
driven by the desire to postpone or avoid the risks of more
extreme treatments such as a splenectomy or immunosuppres-
sion.28 Generally, most fatal bleeding has been reported to
occur in ITP patients whose platelet counts wereo30  109/L.
Thus, a platelet count of430  109/L is generally considered
safe for patients who do not perform physical labor, such asFig. 4. Changes in platelet counts during the course of treatment in
case 2.
ITP treated with traditional herbal medicinescarpenters or farmers.29 In this study, we deﬁned remission as
Z26 consecutive weeks of a platelet countZ50  109/L after
discontinuing the herbal medicine with no other ITP
treatment, 30 and complete remission was deﬁned as a
platelet count Z100  109/L.
Traditional herbal medicine has been used for thousands of
years in Korea. From the point of view of pathology, in
traditional medicine based on syndrome differentiation, ITP is
caused by blood heat expelling the blood from the vessels,
which induces bleeding, such as epistaxis, plurimenorrhea,
ulemorrhagia, and petechiae. After bleeding, the extravasated
blood stagnates in the body (blood stasis) and inhibits
circulation, so as to aggravate the bleeding.31 In the chronic
stage, the retained blood heat and extravasated blood, which
act like toxins, can exhaust Qi and Yin, resulting in their
deﬁciency.32 Thus, chronic ITP is treated primarily by
dissipating blood heat, removing toxins, promoting blood
circulation, and by tonifYing Qi and nourishing Yin.33,34
In Case 1, the patient was treated with prednisone as an
initial therapy. Prednisone generally shows an initial response
within two weeks,2 but the patient was unresponsive to the
steroid. Thus, an immunosuppressant was added, and the
steroid dose was increased. However, the patient failed to
show any response over three months, and he experienced side
effects, including liver toxicity. The patient ceased the ongoing
conventional therapies and visited our clinic when the disease
had progressed to a chronic stage. We diagnosed him with
persistent ITP and a blood heat–predominant pattern, based
on Yin and Qi deﬁciency complex syndrome, according to the
traditional syndrome differentiation diagnosis system. Thus,
we administered a modiﬁed jigolpium water extract to initially
clear the toxins including the blood heat. He responded well,
and the steroid was tapered, but his platelet count then
decreased again. Next, we changed the herbal medicine to a
modiﬁed seongyutang water extract, invigorating the Qi and
Yin to promote blood circulation. After that, he showed a
continued complete response, and we discontinued the herbal
treatment. Three years later, he exhibited sustained completeEXPLORE ] 2016, Vol. ], No. ] 5
remission, deﬁned, as above, by a platelet count4100  109/L
without treatment.
In Case 2, the patient experienced sustained remission after
steroid therapy in childhood, but thrombocytopenia recurred
with a low platelet level, 8  109/L, in January 2011. She
started to undergo ITP treatment again and continued to take
oral steroids with a platelet count430  109/L for two years.
However, after two years of treatment, she had to discontinue
the steroid treatment because of side effects. She visited our
clinic for an alternative therapy, and we diagnosed her with a
blood-heat subordinate pattern based on Qi and Yin deﬁ-
ciency complex syndrome. Thus, we treated her with a
modiﬁed seongyutang water extract for seven months. She
showed a continued partial response, deﬁned as platelet count
430  109/L.3 Given her busy schedule, the absence of
bleeding allowed us to discontinue the herbal medicine and to
apply a “watchful observation” strategy.29 At about two years
later, her remission continued.
In conclusion, herbal medicine based on TKM offers
potential alternative therapies for patients with persistent or
chronic ITP who do not respond sufﬁciently to the ﬁrst-line
treatments: corticosteroids, IVIG, and anti-D. Still, very little
is known about the biological mechanism of traditional herbal
medicines, and only limited data were generated in this study.
Thus, further studies, including case–control studies and
randomized control trials with larger population sizes, are
needed to demonstrate the efﬁcacy, safety, and biological
mechanism of herbal medicines in the treatment of ITP.CONFLICTS OF INTEREST
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